Sergipe receives 7,900 doses of dengue vaccine
Sergipe has received 7,900 doses of a dengue vaccine produced by the Butantan Institute, aimed initially at health professionals.
Rio begins to administer new dengue vaccine to healthcare professionals
Rio de Janeiro has started administering a new dengue vaccine, developed by the Butantan Institute, exclusively to frontline healthcare workers.
MG starts applying chikungunya vaccine developed by Instituto Butantan
Minas Gerais has begun administering a new chikungunya vaccine developed by Instituto Butantan, designed for adults aged 18 to 59 without immune deficiencies.
SP government anticipates delivery of 1.3 million doses of the Butantan dengue vaccine
The São Paulo government has expedited the delivery of 1.3 million doses of the dengue vaccine from the Butantan Institute to the Ministry of Health, as announced by Governor Tarcísio de Freitas.
SP government announces more dengue vaccine doses and creation of immunobiological hub
The São Paulo government has announced the delivery of an additional 1.3 million doses of the dengue vaccine and the establishment of a new hub for immunobiologicals.
Piauí receives 1st batch of dengue vaccine to immunize healthcare professionals
The first batch of the dengue vaccine has arrived in Piauí, Brazil, to immunize around 32,200 healthcare workers.
Without own vaccines, Brazil falls behind in the global vaccination race
Brazil's position in the global vaccination race is questioned due to its lack of self-sufficiency and production of vaccines.
Butantan's dengue vaccine starts being administered to healthcare professionals in Campinas
The new dengue vaccine developed by Butantan Institute is now being administered to healthcare professionals in Campinas, Brazil, starting with certain health agents.
Mogi das Cruzes receives more than 4,100 doses of the dengue vaccine produced by Butantã
Mogi das Cruzes has received over 4,137 doses of the Butantan-DV vaccine, the world's first single-dose vaccine against dengue, aimed at protecting local health professionals.
Jacareí receives single-dose vaccine against dengue and starts immunization this Monday (9)
The city of Jacareí in Brazil begins a vaccination campaign against dengue, utilizing a single-dose vaccine amid confirmed cases and a death in the current year.
Lula starts vaccination against dengue with national Butantan-DV vaccine
President Lula announced funding for the Butantan Institute and began a vaccination campaign against dengue using a new Brazilian vaccine.
Lula announces investment of R$ 1.4 billion to increase the productive capacity of the Butantan Institute
Brazilian President Lula da Silva announced a R$ 1.4 billion investment to enhance the Butantan Institute's capacity for vaccine and serum production.
'Pearl Necklace' on Spider Reveals New Unprecedented Parasite Species in Brazil
Researchers at the Butantan Institute in São Paulo discovered a new species of parasitic mite, Araneothrombium brasiliensis, on a juvenile spider, marking the second such discovery in Brazil in 40 years.
Dengue Vaccine: Piracicaba Begins Vaccination with Butantan-DV for Health Professionals
Piracicaba has commenced its dengue vaccination campaign with the Butantan-DV vaccine, initially targeting primary healthcare professionals starting Monday, September 9.
SP begins vaccination against dengue with Butantan-DV on Monday (9)
The São Paulo government announced the start of a dengue vaccination campaign using Butantan-DV on Monday, targeting about 216,000 primary health care professionals across all municipalities in the state.
Dengue vaccine: the state of SP starts vaccination campaign with Butantan-DV on Monday in all municipalities
The government of São Paulo begins a vaccination campaign against dengue with the Butantan-DV vaccine on Monday, encompassing all 645 municipalities in the state.
Lula and Tarcísio are set to share the stage at an event at the Butantan Institute
President Lula and Governor Tarcísio de Freitas are scheduled to share the stage for a ceremony to announce funding for the expansion of the Butantan Institute in São Paulo next week.
Young biologist exchanges fear for science and today studies ant venom against cancer
Gustavo Pinheiro, a 25-year-old biologist at the Butantan Institute, transformed his childhood fear into a research endeavor to find cancer-fighting compounds in ant venom.